Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

ClinicalTrials.gov ID: NCT05052697

Public ClinicalTrials.gov record NCT05052697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA IN HEALTHY INDIVIDUALS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be divided into two substudies - Substudy A (SSA) and Substudy B (SSB) Substudy A This is a Phase 1 randomized substudy to evaluate the safety and immunogenicity of monovalent influenza modRNA vaccine (mIRV) and bivalent influenza modRNA vaccine (bIRV) at various dose levels, and quadrivalent influenza modRNA vaccine (qIRV), in participants 65 to 85 years of age. Participants will receive at Vaccination 1 either: * 1 of 4 dose levels of mIRV (either A or B Strain), * 1 of 4 dose levels of bIRV (containing both A and B strains), * qIRV (at 1 dose level), or * A licensed quadrivalent influenza vaccine (QIV). At approximately 8 weeks following Vaccination 1, participants will be unblinded and QIV (Vaccination 2) administered to participants not having previously received this at Vaccination 1. Additionally, participants who previously received QIV at Vaccination 1 will receive one of the following for Vaccination 2: * mIRV encoding A strain at dose level 4, or * mIRV encoding B strain at dose level 4. Substudy B This is a randomized substudy to evaluate the safety and immunogenicity of the following vaccination schedules in participants 65 to 85 years of age: 2-Visit Schedules * 2 doses of qIRV (at a dose level 1), administered 21 days apart. * 2 doses of licensed QIV, administered 21 days apart (as a control group) * A dose of licensed QIV following by a dose of bIRV encoding 2 A strains at dose level combination 1 or 2, administered 21 days apart. 1-Visit Schedules * A dose of licensed QIV administered concurrently in the opposite arm with bIRV encoding 2 A strains at dose level combination 1 or 2. * A dose of bIRV encoding 2 A strains administered concurrently in the opposite arm with a dose of bIRV encoding 2 B strains.at dose level 1. * A dose of qIRV encoding 2 A strains and 2 B strains at dose level 2 (at one of two possible dose level combinations). * A dose of qIRV encoding 2 A strains and 2 B strains at dose level 3. * 1 dose of licensed QIV (as a control group). Substudy B In participants 18 to 64 years of age: -A dose of qIRV encoding 2 A strains and 2 B strains at a dose level combination 1 or 2.

Study identification

NCT ID
NCT05052697
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
1,158 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 12, 2021
Primary completion
Jan 26, 2023
Completion
Jan 26, 2023
Last update posted
Mar 11, 2024

2021 – 2023

United States locations

U.S. sites
100
U.S. states
22
U.S. cities
61
Facility City State ZIP Site status
North Alabama Research Center Athens Alabama 35611
The Heart Center Athens Alabama 35611
Arizona Heart Rhythm Center Phoenix Arizona 85016
HOPE Research Institute Phoenix Arizona 85018
The Pain Center of Arizona Phoenix Arizona 85018
Noble Clinical Research Tucson Arizona 85704
Pima Heart and Vascular Tucson Arizona 85704
Inland Valley Cardiovascular Center Murrieta California 92563
Orange County Heart Institute Orange California 92868
Artemis Institute for Clinical Research Riverside California 92503
Orange County Research Center Tustin California 92780
Pediatrics-Infectious Diseases - Clinical Trials Center at University of Colorado Anschutz Medical C Aurora Colorado 80045
UCHealth Heart and Vascular Center - Anschutz Medical Campus Aurora Colorado 80045
Yale University School of Medicine New Haven Connecticut 06510
Yale Cardiology New Haven Connecticut 06519
Yale University School of Medicine New Haven Connecticut 06519
Alliance for Multispecialty Research, LLC Coral Gables Florida 33134
Halifax Health Medical Center Daytona Beach Florida 32114
NYU Langone Cardiology Associates Delray Beach Florida 33484
First Coast Heart & Vascular Center Fleming Island Florida 32003
Fleming Island Center for Clinical Research Fleming Island Florida 32003
Proactive Clinical Research,LLC Fort Lauderdale Florida 33308
Alliance for Multispecialty Research, LLC Fort Myers Florida 33912
Millennium Physician Group Fort Myers Florida 33912
Robert B. Pritt, DO Fort Myers Florida 33912
Direct Helpers Research Center. Hialeah Florida 33012
Best Quality Research,Inc. Hialeah Florida 33016
Elixia Infectious Disease, LLC Hollywood Florida 33024
First Coast Heart & Vascular Center Jacksonville Florida 32216
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Jacksonville Florida 32256
First Coast Cardiovascular Institute Jacksonville Florida 32256
Premier Cardiology and Vascular Associates Maitland Florida 32751
LMG Research Miami Florida 33125
Millennium Clinical Research Miami Florida 33125
Optimus U Corporation Miami Florida 33125
Suncoast Research Group Miami Florida 33135
Schiff Center for Liver Diseases/University of Miami Miami Florida 33136
University of Miami Hospital Miami Florida 33136
Dr Gerardo A. Polanco, MD Miami Florida 33156
Research Institute of South Florida Miami Florida 33173
Entrust Clinical Research Miami Florida 33176
Jackson Medical Group Cardiac Care Miami Florida 33176
Miami Dade Medical Research Institute, LLC Miami Florida 33176
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
Central Florida Cardiology Group Orlando Florida 32803
Innovation Medical Research Center Palmetto Bay Florida 33157
DBC Research USA Pembroke Pines Florida 33029
Progressive Medical Research Port Orange Florida 32127
My Cardiologist South Miami Florida 33143
Precision Clinical Research Sunrise Florida 33351
Genesis Clinical Research, LLC Tampa Florida 33603
Conquest Research Winter Park Florida 32789
Centricity Research Columbus Georgia Multispecialty Columbus Georgia 31904
IACT Health Columbus Georgia 31904
IACT Health Rincon Georgia 31326
East-West Medical Research Institute Honolulu Hawaii 96814
University of Iowa Iowa City Iowa 52242
Alliance for Multispecialty Research, LLC Wichita Kansas 67205
Alliance for Multispecialty Research, LLC Wichita Kansas 67207
Heartland Cardiology, LLC Wichita Kansas 67226
Centennial Medical Group Elkridge Maryland 21075
Associates of Cardiology Silver Spring Maryland 20910
Henry Ford Hospital Detroit Michigan 48202
Pioneer Heart Institute Lincoln Nebraska 68506
Velocity Clinical Research, Norfolk Norfolk Nebraska 68701
Meridian Clinical Research - 3345 North 107th Street Omaha Nebraska 68134
Velocity Clinical Research, Omaha Omaha Nebraska 68134
Sanjay Vohra, MD, F.A.C.C. Henderson Nevada 89074
Wr-Crcn, Llc. Las Vegas Nevada 89106
Excel Clinical Research, LLC Las Vegas Nevada 89109
Las Vegas Clinical Trials North Las Vegas Nevada 89030
Hassman Research Institute Berlin New Jersey 08009
Penn Medicine Somers Point New Jersey 08244
South Jersey Infectious Disease Somers Point New Jersey 08244
NYU Langone - Center for the Prevention of Cardiovascular Disease New York New York 10016
NYU Langone Health New York New York 10016
Rochester General Hospital Infectious Disease Rochester New York 14621
Rochester General Hospital Rochester New York 14621
University of Rochester Medical Center Rochester New York 14642
Upstate Health Care Center-University Cardiovascular Group of Syracuse Syracuse New York 13202
SUNY Upstate Medical University Global Health Research Unit Syracuse New York 13215
M3-Emerging Medical Research, LLC Durham North Carolina 27704
Carolina Institute for Clinical Research Fayetteville North Carolina 28303
Monroe Biomedical Research Monroe North Carolina 28112
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Aventiv Research Inc. Columbus Ohio 43213
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213
Columbus Cardiovascular Associates, Inc Columbus Ohio 43213
Pennsylvania Heart and Vascular Group Jenkintown Pennsylvania 19046
Main Street Physician's Care Little River South Carolina 29566
Prolato Clinical Research Center Houston Texas 77054
DM Clinical Research Houston Texas 77065
DM Clinical Research Humble Texas 77338
Cedar Health Research Irving Texas 75062
Harmony Heart Group Plano Texas 75093
Mt Olympus Medical Research Sugar Land Texas 77479
DM Clinical Research Tomball Texas 77375
Northwest Heart Center Tomball Texas 77375
Centricity Research Suffolk Primary Care Suffolk Virginia 23435
Sentara BelleHarbour Suffolk Virginia 23435

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05052697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2024 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05052697 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →